Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Formyl peptide receptor 2 determines sex-specific differences in the progression of nonalcoholic fatty liver disease and steatohepatitis
Chanbin Lee, Ji‐Eun Kim, Jinsol Han, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Association between SII and hepatic steatosis and liver fibrosis: A population-based study
Ruijie Xie, Mengde Xiao, Lihong Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 141
A researcher’s guide to preclinical mouse NASH models
Suchira Gallage, Jose Efren Barragan Avila, Pierluigi Ramadori, et al.
Nature Metabolism (2022) Vol. 4, Iss. 12, pp. 1632-1649
Closed Access | Times Cited: 101
Formyl peptide receptor 2 is an emerging modulator of inflammation in the liver
Chanbin Lee, Jinsol Han, Youngmi Jung
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 2, pp. 325-332
Open Access | Times Cited: 22
Fatty Liver Index (FLI) is the best score to predict MASLD with 50% lower cut-off value in women than in men
Lucilla Crudele, Carlo De Matteis, Fabio Novielli, et al.
Biology of Sex Differences (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 9
Aging promotes metabolic dysfunction-associated steatotic liver disease by inducing ferroptotic stress
Kuo Du, Liuyang Wang, Ji Hye Jun, et al.
Nature Aging (2024) Vol. 4, Iss. 7, pp. 949-968
Closed Access | Times Cited: 9
Vitamin D improves hepatic steatosis in NAFLD via regulation of fatty acid uptake and β-oxidation
Tingwan Du, Xiang Lian, Jingjing Zhang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 19
Proximity-inducing modalities: the past, present, and future
Sameek Singh, Wenzhi Tian, Zachary C. Severance, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 16, pp. 5485-5515
Closed Access | Times Cited: 16
BMI trajectories are associated with NAFLD and advanced fibrosis via aging-inflammation mediation
Haiyang Peng, Zhibo Zhao, Jian-Ping Gong, et al.
BMC Public Health (2025) Vol. 25, Iss. 1
Open Access
The N-formyl peptide receptors: much more than chemoattractant receptors. Relevance in health and disease
Filomena Napolitano, Nunzia Montuori
Frontiers in Immunology (2025) Vol. 16
Open Access
Recipient Toll-like Receptor 4 Determines the Outcome of Ischemia-Reperfusion Injury in Steatotic Liver Transplantation in Mice
Kosuke Tanaka, Yoichiro Uchida, Kentaro Kadono, et al.
American Journal of Transplantation (2025)
Closed Access
Formyl peptide receptor 2: a potential therapeutic target for inflammation-related diseases
Jiaying Wang, Zhishuo Miao, Yinhuang Gao, et al.
Pharmacological Reports (2025)
Closed Access
The prevalence of MAFLD and its association with atrial fibrillation in a nationwide health check-up population in China
Fang Lei, Juan‐Juan Qin, Xiaohui Song, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 26
Tetrahydrocurcumin Alleviates Metabolic Dysfunction-Associated Steatohepatitis in Mice by Regulating Serum Lipids, Bile Acids, and Gut Microbiota
Peng Shang, Moran Meng, Ping Luo, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 895-895
Open Access
Exploring the severity and risk factors of non-alcoholic fatty liver disease using the SAF scoring system
Xinxin Li, Shiyu Wang, Ziyu Zhang, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Structural characterization ofPoria cocosoligosaccharides and their effects on the hepatic metabolome in high-fat diet-fed mice
Lin Zhu, Guangming Chen, Yanlei Guo, et al.
Food & Function (2022) Vol. 13, Iss. 12, pp. 6813-6829
Closed Access | Times Cited: 16
Phthalate Biomarkers Composition in Relation to Fatty Liver: Evidence from Epidemiologic and in vivo studies
Shucong Chen, Hang Liu, Yulian Sun, et al.
The Science of The Total Environment (2024) Vol. 924, pp. 171607-171607
Closed Access | Times Cited: 3
NAFLD-Related HCC: Focus on the Latest Relevant Preclinical Models
Jing Fang, Séverine Celton‐Morizur, Chantal Desdouets
Cancers (2023) Vol. 15, Iss. 14, pp. 3723-3723
Open Access | Times Cited: 8
Recent Insights into the Biomarkers, Molecular Targets and Mechanisms of Non-Alcoholic Steatohepatitis-Driven Hepatocarcinogenesis
Anna Kakehashi, Shugo Suzuki, Hideki Wanibuchi
Cancers (2023) Vol. 15, Iss. 18, pp. 4566-4566
Open Access | Times Cited: 8
Implications of innate immune sexual dimorphism for MASLD pathogenesis and treatment
Richell Booijink, Prakash Ramachandran, Ruchi Bansal
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 7, pp. 614-627
Closed Access | Times Cited: 2
Chemotactic cytokines secreted from Kupffer cells contribute to the sex-dependent susceptibility to non-alcoholic fatty liver diseases in mice
Yong‐Hyun Han, Haena Choi, Hyeonji Kim, et al.
Life Sciences (2022) Vol. 306, pp. 120846-120846
Closed Access | Times Cited: 11
Molecular insights of a CBP/β-catenin-signaling inhibitor on nonalcoholic steatohepatitis-induced liver fibrosis and disorder
Kenzaburo Yamaji, Sadahiro Iwabuchi, Yuko Tokunaga, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115379-115379
Open Access | Times Cited: 6
FMO2 ameliorates nonalcoholic fatty liver disease by suppressing ER-to-Golgi transport of SREBP1
Changle Ke, Changchen Xiao, Jiamin Li, et al.
Hepatology (2023)
Closed Access | Times Cited: 5
Testosterone Exacerbates the Formation of Liver Cancer Induced by Environmental N-Nitrosamines Exposure: Potential Mechanisms and Implications for Human Health
Xin Yin, H Gu, Dan Ning, et al.
OncoTargets and Therapy (2024) Vol. Volume 17, pp. 395-409
Open Access | Times Cited: 1
Associations between serum ferritin baselines and trajectories and the incidence of metabolic dysfunction-associated steatotic liver disease: a prospective cohort study
Ziping Song, Xinlei Miao, Xiaoling Xie, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Age at menopause and risk of metabolic dysfunction-associated fatty liver disease: A 14-year cohort study
Ehn-Young Kim, Yae-Ji Lee, Yu‐Jin Kwon, et al.
Digestive and Liver Disease (2024) Vol. 56, Iss. 11, pp. 1880-1886
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top